volume 273 pages 116364

The role of the methoxy group in approved drugs

Debora Chiodi 1
Yoshihiro Ishihara 2
1
 
Department of Chemistry, Takeda Pharmaceuticals, 9625 Towne Centre Drive, San Diego, CA, 92121, USA
2
 
Department of Chemistry, Vividion Therapeutics, 5820 Nancy Ridge Drive, San Diego, CA, 92121, USA
Publication typeJournal Article
Publication date2024-07-01
scimago Q1
wos Q1
SJR1.142
CiteScore11.3
Impact factor5.9
ISSN02235234, 17683254
Organic Chemistry
Drug Discovery
General Medicine
Pharmacology
Abstract
The methoxy substituent is prevalent in natural products and, consequently, is present in many natural product-derived drugs. It has also been installed in modern drug molecules with no remnant of natural product features because medicinal chemists have been taking advantage of the benefits that this small functional group can bestow on ligand-target binding, physicochemical properties, and ADME parameters. Herein, over 230 methoxy-containing small-molecule drugs, as well as several fluoromethoxy-containing drugs, are presented from the vantage point of the methoxy group. Biochemical mechanisms of action, medicinal chemistry SAR studies, and numerous X-ray cocrystal structures are analyzed to identify the precise role of the methoxy group for many of the drugs and drug classes. Although the methoxy substituent can be considered as the hybridization of a hydroxy and a methyl group, the combination of these functionalities often results in unique effects that can amount to more than the sum of the individual parts.
Found 
Found 

Top-30

Journals

1
2
3
Bioorganic Chemistry
3 publications, 6.67%
European Journal of Medicinal Chemistry
2 publications, 4.44%
International Journal of Biological Macromolecules
2 publications, 4.44%
MolBank
2 publications, 4.44%
ACS Omega
2 publications, 4.44%
Journal of Molecular Structure
2 publications, 4.44%
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 2.22%
Antioxidants
1 publication, 2.22%
Chemistry and Biodiversity
1 publication, 2.22%
Molecules
1 publication, 2.22%
Chemico-Biological Interactions
1 publication, 2.22%
RSC Medicinal Chemistry
1 publication, 2.22%
Future Medicinal Chemistry
1 publication, 2.22%
Journal of Medicinal Chemistry
1 publication, 2.22%
Inorganic Chemistry Communication
1 publication, 2.22%
Biochemical Pharmacology
1 publication, 2.22%
Inorganic Chemistry
1 publication, 2.22%
Acta Crystallographica Section E: Crystallographic Communications
1 publication, 2.22%
Chem Catalysis
1 publication, 2.22%
Polyhedron
1 publication, 2.22%
Antibiotics
1 publication, 2.22%
Current Medicinal Chemistry
1 publication, 2.22%
Asian Journal of Chemistry
1 publication, 2.22%
Cell Chemical Biology
1 publication, 2.22%
Zeitschrift fur Kristallographie - New Crystal Structures
1 publication, 2.22%
ChemistrySelect
1 publication, 2.22%
ChemCatChem
1 publication, 2.22%
Computational and Theoretical Chemistry
1 publication, 2.22%
ChemMedChem
1 publication, 2.22%
Food Bioscience
1 publication, 2.22%
1
2
3

Publishers

2
4
6
8
10
12
14
16
18
20
Elsevier
19 publications, 42.22%
American Chemical Society (ACS)
6 publications, 13.33%
MDPI
5 publications, 11.11%
Taylor & Francis
4 publications, 8.89%
Wiley
4 publications, 8.89%
Springer Nature
2 publications, 4.44%
Royal Society of Chemistry (RSC)
1 publication, 2.22%
International Union of Crystallography (IUCr)
1 publication, 2.22%
Bentham Science Publishers Ltd.
1 publication, 2.22%
Asian Journal of Chemistry
1 publication, 2.22%
Walter de Gruyter
1 publication, 2.22%
2
4
6
8
10
12
14
16
18
20
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
45
Share
Cite this
GOST |
Cite this
GOST Copy
Chiodi D. et al. The role of the methoxy group in approved drugs // European Journal of Medicinal Chemistry. 2024. Vol. 273. p. 116364.
GOST all authors (up to 50) Copy
Chiodi D., Ishihara Y. The role of the methoxy group in approved drugs // European Journal of Medicinal Chemistry. 2024. Vol. 273. p. 116364.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.ejmech.2024.116364
UR - https://linkinghub.elsevier.com/retrieve/pii/S0223523424002447
TI - The role of the methoxy group in approved drugs
T2 - European Journal of Medicinal Chemistry
AU - Chiodi, Debora
AU - Ishihara, Yoshihiro
PY - 2024
DA - 2024/07/01
PB - Elsevier
SP - 116364
VL - 273
PMID - 38781921
SN - 0223-5234
SN - 1768-3254
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Chiodi,
author = {Debora Chiodi and Yoshihiro Ishihara},
title = {The role of the methoxy group in approved drugs},
journal = {European Journal of Medicinal Chemistry},
year = {2024},
volume = {273},
publisher = {Elsevier},
month = {jul},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0223523424002447},
pages = {116364},
doi = {10.1016/j.ejmech.2024.116364}
}